The nation of Zimbabwe has declined a major American healthcare agreement valued at $367m (£272m) spanning five years due to the United States' request for sensitive information.
This move became public following a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
A government representative later explained that the United States was seeking biological samples for research and profit but was not willing to guarantee the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate task of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for further negotiations to reach a deal agreeable to all parties so the country's critical HIV programme can be sustained.
Broader Implications
This rejection follows a comparable case in neighbouring Kenya, where a high court suspended a related deal with the US after legal challenges were filed about the safety of citizens' health data.
Since returning to office last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump stated its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance openness and responsibility.
As per statements, Sixteen African countries have so far agreed to similar health pacts, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment via American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that shared data," his statement read.
"Put simply, our country would provide the raw materials for medical research without any assurance that the final treatments would be accessible to our citizens should a future health crisis emerge."
National Interest and International Frameworks
He also said that the US's withdrawal from the global health body and its push of bilateral health agreements were upending structures already established through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage future pandemics.
"This framework is designed to guarantee that when a nation provides its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage ongoing discussions with our American counterparts on how subsequent co-operation might be arranged in a manner that honours the sovereignty and dignity of each country."
Health Experts Reaction
A leading public health body expressed it understood the official position, but recommended that negotiations should continue given that much of the country's Aids initiatives relied on foreign aid.
"If technical issues arise, including those relating to data governance or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," it added.
This impasse highlights the ongoing debate between receiving much-needed foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.